Pharmacogenomics Market Competitive Landscape and Key Providers | #precision pharmacogenomics # EHR drug-genotype alerts # oncology genotype panels # CYP2C19 cardiovascular dosing # personalized prescribing # adverse drug reaction prevention # value-based pharmacogenetic testing # genomic-guided medications # safer drug choice # genomic medicine integration

Videnskab og teknologi

Pharmacogenomics Market Competitive Landscape and Key Providers

The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion.